135 related articles for article (PubMed ID: 38608394)
1. Placental and serum levels of human α-Klotho in preeclampsia & intra-uterine growth retardation: A potential sensitive biomarker?
Sabren S; Hagar T; Khateeb N; Evgeny F; Yara FN; Perlitz Y; Farid N
Pregnancy Hypertens; 2024 Jun; 36():101115. PubMed ID: 38608394
[TBL] [Abstract][Full Text] [Related]
2. Circulating and placental endoglin concentrations in pregnancies complicated by intrauterine growth restriction and preeclampsia.
Jeyabalan A; McGonigal S; Gilmour C; Hubel CA; Rajakumar A
Placenta; 2008 Jun; 29(6):555-63. PubMed ID: 18462791
[TBL] [Abstract][Full Text] [Related]
3. The anti-aging factor α-klotho during human pregnancy and its expression in pregnancies complicated by small-for-gestational-age neonates and/or preeclampsia.
Miranda J; Romero R; Korzeniewski SJ; Schwartz AG; Chaemsaithong P; Stampalija T; Yeo L; Dong Z; Hassan SS; Chrousos GP; Gold P; Chaiworapongsa T
J Matern Fetal Neonatal Med; 2014 Mar; 27(5):449-57. PubMed ID: 23808483
[TBL] [Abstract][Full Text] [Related]
4. Myeloperoxidase in the plasma and placenta of normal pregnant women and women with pregnancies complicated by preeclampsia and intrauterine growth restriction.
Hung TH; Chen SF; Lo LM; Li MJ; Yeh YL; Hsieh TT
Placenta; 2012 Apr; 33(4):294-303. PubMed ID: 22264587
[TBL] [Abstract][Full Text] [Related]
5. PTX3 as a potential endothelial dysfunction biomarker for severity of preeclampsia and IUGR.
Cozzi V; Garlanda C; Nebuloni M; Maina V; Martinelli A; Calabrese S; Cetin I
Placenta; 2012 Dec; 33(12):1039-44. PubMed ID: 23062219
[TBL] [Abstract][Full Text] [Related]
6. First-trimester serum analytes, biophysical tests and the association with pathological morphometry in the placenta of pregnancies with preeclampsia and fetal growth restriction.
Odibo AO; Zhong Y; Longtine M; Tuuli M; Odibo L; Cahill AG; Macones GA; Nelson DM
Placenta; 2011 Apr; 32(4):333-8. PubMed ID: 21324404
[TBL] [Abstract][Full Text] [Related]
7. Endoglin in pregnancy complicated by fetal intrauterine growth restriction in normotensive and preeclamptic pregnant women: a comparison between preeclamptic patients with appropriate-for-gestational-age weight infants and healthy pregnant women.
Laskowska M; Laskowska K; Oleszczuk J
J Matern Fetal Neonatal Med; 2012 Jun; 25(6):806-11. PubMed ID: 21793708
[TBL] [Abstract][Full Text] [Related]
8. Systemic and placental α-klotho: Effects of preeclampsia in the last trimester of gestation.
Loichinger MH; Towner D; Thompson KS; Ahn HJ; Bryant-Greenwood GD
Placenta; 2016 May; 41():53-61. PubMed ID: 27208408
[TBL] [Abstract][Full Text] [Related]
9. Association between adverse pregnancy outcome and imbalance in angiogenic regulators and oxidative stress biomarkers in gestational hypertension and preeclampsia.
Turpin CA; Sakyi SA; Owiredu WK; Ephraim RK; Anto EO
BMC Pregnancy Childbirth; 2015 Aug; 15():189. PubMed ID: 26303772
[TBL] [Abstract][Full Text] [Related]
10. Apparent systemic 11ß-dehydroxysteroid dehydrogenase 2 activity is increased in preeclampsia but not in intrauterine growth restriction.
Vasku M; Kleine-Eggebrecht N; Rath W; Mohaupt MG; Escher G; Pecks U
Pregnancy Hypertens; 2018 Jan; 11():7-11. PubMed ID: 29523277
[TBL] [Abstract][Full Text] [Related]
11. Expression of Myostatin in Intrauterine Growth Restriction and Preeclampsia Complicated Pregnancies and Alterations to Cytokine Production by First-Trimester Placental Explants Following Myostatin Treatment.
Peiris HN; Georgiou H; Lappas M; Kaitu'u-Lino T; Salomón C; Vaswani K; Rice GE; Mitchell MD
Reprod Sci; 2015 Oct; 22(10):1202-11. PubMed ID: 25736326
[TBL] [Abstract][Full Text] [Related]
12. [Mast cells, histamine and development of the placental vascular network in pregnancies complicated by preeclampsia and intrauterine growth retardation].
Szewczyk G; Szewczyk A; Pyzlak M; Klimkiewicz J; Smiertka W; Szukiewicz D
Ginekol Pol; 2005 Sep; 76(9):727-34. PubMed ID: 16417085
[TBL] [Abstract][Full Text] [Related]
13. Placental and serum levels of human Klotho in severe preeclampsia: A potential sensitive biomarker.
Uzun Cilingir I; Varol F; Gurkan H; Sutcu H; Atli E; Eker D; Inan C; Erzincan S; Sayin C
Placenta; 2019 Sep; 85():49-55. PubMed ID: 31446221
[TBL] [Abstract][Full Text] [Related]
14. Discordant clinical presentations of preeclampsia and intrauterine fetal growth restriction with similar pro- and anti-angiogenic profiles.
Alahakoon TI; Zhang W; Trudinger BJ; Lee VW
J Matern Fetal Neonatal Med; 2014 Dec; 27(18):1854-9. PubMed ID: 24397483
[TBL] [Abstract][Full Text] [Related]
15. Use of placental growth factor and uterine artery doppler pulsatility index in pregnancies involving intrauterine fetal growth restriction or preeclampsia to predict perinatal outcomes.
Gomez-Roig MD; Mazarico E; Sabria J; Parra J; Oton L; Vela A
Gynecol Obstet Invest; 2015; 80(2):99-105. PubMed ID: 25924544
[TBL] [Abstract][Full Text] [Related]
16. Placental mRNA expression of angiopoietins (Ang)-1, Ang-2 and their receptor Tie-2 is altered in pregnancies complicated by preeclampsia.
Kappou D; Sifakis S; Androutsopoulos V; Konstantinidou A; Spandidos DA; Papantoniou N
Placenta; 2014 Sep; 35(9):718-23. PubMed ID: 25047691
[TBL] [Abstract][Full Text] [Related]
17. Expression of 52-kDa FK506-binding protein (FKBP52) in human placenta complicated by preeclampsia and intrauterine growth restriction.
Acar N; Ustunel I
Anal Quant Cytopathol Histpathol; 2015 Apr; 37(2):87-95. PubMed ID: 26065228
[TBL] [Abstract][Full Text] [Related]
18. Differential levels of amino acid transporters System L and ASCT2, and the mTOR protein in placenta of preeclampsia and IUGR.
Aiko Y; Askew DJ; Aramaki S; Myoga M; Tomonaga C; Hachisuga T; Suga R; Kawamoto T; Tsuji M; Shibata E
BMC Pregnancy Childbirth; 2014 May; 14():181. PubMed ID: 24886642
[TBL] [Abstract][Full Text] [Related]
19. PlGF in a clinical setting of pregnancies at risk of preeclampsia and/or intrauterine growth restriction.
Cetin I; Mazzocco MI; Giardini V; Cardellicchio M; Calabrese S; Algeri P; Martinelli A; Todyrenchuk L; Vergani P
J Matern Fetal Neonatal Med; 2017 Jan; 30(2):144-149. PubMed ID: 27028483
[TBL] [Abstract][Full Text] [Related]
20. Association of fetal-derived hypermethylated RASSF1A concentration in placenta-mediated pregnancy complications.
Kim MJ; Kim SY; Park SY; Ahn HK; Chung JH; Ryu HM
Placenta; 2013 Jan; 34(1):57-61. PubMed ID: 23187089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
